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Aim of the study: Lymphomas are 
a heterogeneous group of tumours of 
lymphoid tissue in which there is an 
abnormal proliferation of cells of the 
lymphatic system. The literature notes 
a gradual increase in the incidence of 
this type of cancer in the whole pop-
ulation. The aim of the study was to 
evaluate whether the above tendency 
occurs in the head and neck area.
Material and methods: In the years 
2005–2014, at the Otolaryngology and 
Laryngological Oncology Department 
of the Upper Silesian Medical Centre 
in Katowice, 77 cases of lymphoma 
were recorded, 58 of which were ana-
lysed in terms of location, histological 
type, age and sex of the patient, and 
the presence of risk factors. 
Results: The vast majority of them 
were non-Hodgkin’s lymphomas (NHL) 
– 67.53%. Hodgkin’s lymphomas (HL) 
accounted for only a small fraction of 
diagnoses (7.79%). In terms of his-
topathological types, in most cases 
of NHL, there occurred diffuse large 
B-cell lymphomas (DLBCL) – 51.92%. 
The most common location was the 
lymph nodes, representing the location 
of the primary lesion in more than half 
of the cases. As regards the extranodal 
location, the Waldeyer ring dominated 
(54.54%) along with the palatal tonsil 
(40.90%).
There has been a  significant upward 
trend, especially in the incidence of 
NHL.
Key words: otolaryngology, DLBCL, 
NHL, histopathology, epidemiology.
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Introduction
In recent decades, there has been a steady increase in the incidence of 
non-Hodgkin’s lymphomas (NHL) of 2–4% per year [1, 2]. These observations 
have been made throughout the world [3–5]. Reports from Denmark suggest 
that in the years 1970–1985 the number of cases doubled [6].
Lymphoma is a malignant lymphoproliferative disease, which is generally 
divided into Hodgkin’s lymphomas (HL) and NHL. According to the National 
Cancer Registry, about 2% of cancer cases in Poland are NHL and about 0.5% 
are HL.
Non-Hodgkin’s lymphomas can be located in the lymph nodes or beyond 
them. The second location can affect all organs. This is most commonly the 
skin, stomach, central nervous system, and Waldeyer’s ring. The head and 
neck area is one of the most common locations of extranodal lymphomas, 
after the location in the gastrointestinal tract, and represents about 5% of 
malignant neoplasms of the head and neck [7].
According to the Lugano classification for staging of nodal lymphomas 
from 2014, which is a modification of the Ann Arbor classification, the Wald-
eyer ring, spleen, thymus, appendix, and Peyer’s patches were considered as 
nodal tissue [8]. The authors of this publication, when describing the loca-
tion of the tumour, treated the Waldeyer ring (which includes the palatine, 
lingual, and pharyngeal tonsils), nasal cavity, and paranasal sinuses, as well 
as parotid glands, as being extranodal locations of lymphoma, which facili-
tated clinical and pathological evaluation of the location of lesions.
The 2008 WHO classification identified six main groups of lymphomas:
•	 precursor B-cell and NK/T-cell lymphoma,
•	 mature B-cell lymphoma,
•	 mature NK/T-cell lymphoma,
•	 post-transplantation lymphoproliferative disorders,
•	 Hodgkin’s lymphoma,
•	 neoplasms of histiocytic and dendritic cells.
The group of B-cell neoplasms was divided into:
•	 aggressive lymphomas, which include diffuse large B-cell lymphoma  
(DLBCL) and Burkitt’s lymphoma,
•	 slow lymphomas – mantle cell, follicular, and marginal zone lymphomas [9].
The vast majority of NHL cases are B-cell lymphomas preceded only by 
DLBCL, which according to various authors constitutes from 32.9 [9] to 71.9% 
[10] of all cases. It is the most common type of lymphoma in Poland [10]. 
Alli’s observations in South African population the most common head and 
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neck lymphomas were plasmablastic lymphoma (31.55%) 
and DLBCL (30.75%) [11].
The aim of the study was a retrospective analysis of 
cases of lymphomas within the head and neck area, and 
a description of their location and histological type, as well 
as observation of whether there has been an increase in 
incidence in the last decade.
Material and methods
A retrospective study was conducted of the medical 
records of patients treated in the Department of Otolar-
yngology and Laryngological Oncology of the Upper Sile-
sian Medical Centre in Katowice in the years 2004–2015, 
in whom head or neck tumours were initially diagnosed. In 
the given period of time, there was no significant increase 
in the number of patients admitted and operated, and the 
diagnoses of patients did not differ from previous years 
and were not focused on neoplastic diseases. The study 
included patients in whom, based on histopathological ex-
amination of the removed tumour, a primary lymphoma 
was diagnosed. The collected data were analysed in terms 
of location of lesions, histological type of lymphoma, Ann 
Arbor staging, as well as the sex and age of the patients. 
Risk factors such as HIV infection (human immunodefi-
ciency virus), HCV (hepatitis C virus), and HBV (hepatitis B 
virus) were checked.
Histopathological classification was made according to 
the 2008 WHO classification of haematopoietic and lym-
phatic system tumours in the Department of Pathology of 
the Upper Silesian medical Centre and was carried out by 
the same pathologist.
Statistical evaluation of the incidence of lesions in the 
studied period of time was made based on regression and 
correlation analysis.
Results
Seventy-seven head and neck lymphomas were diag-
nosed in the years 2004–2015. In the case of 19 patients, 
a pathologist diagnosed lymphomas; however, to specify 
the type of the cell line from which it originated, it was 
necessary to further verify the material at the Institute of 
Oncology in Gliwice, so 58 neoplasms were subjected to 
final analysis. The test group was slightly dominated by 
women – 53.45%. The mean age was 60.7 (±16.06) years 
and was lower among men (46 ±2.83) than women (63.5 
±20.5). None of the patients had HCV, HBV, or HIV infection. 
Fifty-two cases (67.53%) of non-Hodgkin (NHL) and 
six (7.79%) Hodgkin’s lymphomas were identified (HL). In 
each case, HL was located in the nodes.
Non-Hodgkin’s lymphoma in the head and neck area 
was usually observed in the lymph nodes, nasopharynx, 
and salivary glands (Table 1). All lymphomas within the 
sinuses were from B cells, while in the nasal cavity there 
was only one case of T-cell phenotype. The most common 
histological types of NHL were DLBCL, representing 51.92% 
of the cases, and follicular lymphoma – 15.38 %, followed 
by T-cell and mantle cell lymphomas (9.61% each), and 
marginal zone lymphoma – 7.69%.
DLBCL was the most common in both women and men, 
mantle cell lymphoma dominated in men, and the margin-
al zone and follicular lymphomas in women. HL was ob-
served more frequently in men. In this analysis, there was 
no statistically significant difference. The ratio of males to 
females in the case of mantle cells was 4 : 1, and for follic-
ular lymphoma 2 : 5.
According to Ann Arbor staging of lymphomas, in the 
test group 27 patients were stage I, 26 – stage II, 4 – stage III, 
and 1 – stage IV.
The regression and correlation analysis performed in 
different years showed a statistically significant increase 
(Fig. 1) in the incidence of lymphomas, especially non-Hod-
gkin’s type (p = 0.0169) (Table 2). The strength of the re-
lationship between the number of NHLs and subsequent 
years can be described as high (Pearson’s correlation coef-
ficient r = 0.7283). On the basis of the obtained regression 
equation, it can be concluded that an increase of one year 
caused an increase in the number of NHL of 0.78 on aver-
age. Furthermore, the increase in the incidence of NHL in 
Table 1. Location of the primary lesion and the histological type of non-Hodgkin’s lymphoma
Histological type of NHL Location of the primary lesion









Diffuse large B-cell lymphoma 14 6 0 0 3 4 27
Follicular lymphoma 7 0 0 0 1 0 8
Mantle cell lymphoma 2 1 0 2 0 0 5
Marginal zone lymphoma 3 0 0 0 1 0 4
T-cell lymphoma 3 1 0 0 0 1 5
Malt lymphoma 0 0 1 0 0 0 1
Small B-cell lymphoma 1 0 0 0 0 0 1
Small lymphocyticum lymphoma 0 1 0 0 0 0 1
Total 30 9 1 2 5 5 52
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53% was caused by the passage of time. In the case of HL, 
there was no relation between the number of cases and 
subsequent years of observation.
Discussion
The test histopathological material was dominated by 
NHLs, whose number has increased significantly during 
the recent years of observation. HLs were clearly a smaller 
group, which is consistent with other authors’ reports [11–
14]. In 2016 new data was published, which demonstrated 
a significant reduction in NHL morality in the US general 
population, which was initially due to improved survival 
after NHL diagnosis for the three most common subtypes 
(DLBCL, CLL/SLL, and FL) [15].
In the material, NHL lesions were usually located in the 
lymph nodes of the neck, which is confirmed by Tusaliu’s 
research [14]. Takano, on the other hand, reports that the 
mouth and throat are the most common location of lym-
phomas, followed by the lymph nodes [12].
According to Pritinanda, almost 25% of NHLs originate 
from tissue other than the node tissue [16]. The most com-
mon extranodal location, both in the present analysis and 
in the available literature, is the Waldeyer ring, with 20.7% 
of cases.
Regardless of the location of the primary lesion, the 
most commonly diagnosed neoplasm was DLBCL – 35.1%. 
A similar result of 32.9% was reported by Szumera- 
-Ciećkiewicz [10] on the basis of analysis of 11,718 cases 
collected from data from the National Lymphoma Histo-
pathological Registry. The Polish data are consistent with 
the results of studies published in the world [7, 12–14, 17]. 
The primary occupation of the parotid glands by a hy-
perplastic lesion of the lymphatic system was observed 
in 5–10% of patients, which is similar to the results of the 
present analysis [18, 19]. Primary lesions within the sali-
vary glands were surprisingly often (41.38%) observed by 
Triantafillidou in a study of extranodal NHLs in the oral 
cavity and the maxilla-facial area [20]. The most common 
extranodal location in the study of Bagan was the oral 
cavity (44%), followed by the salivary gland (12.4%) and 
palatine tonsils (9.3%) [21].
Different infectious agents and their influence on the 
risk of NHL are described in the literature [13, 22]. The 
most important include Epstein-Barr virus infection, par-
ticularly in favourable conditions of congenital immuno-
deficiency or acquired dysregulation and suppression of 
T lymphocytes (for example, in the course of HIV infection, 
after organ transplant), HH-8b virus (Human Herpes Vi-
rus), HTLV-1 (human lymphotropic virus-1), and the Helico-
bacter pylori or Borrelia burgdorferi infections [13].
The impact of hepatitis C infection on the development 
of B-cell NHL is also discussed [13, 23, 24]. In the case of 
the test group, no patient was diagnosed with HBV, HCV, 
or HIV infections, and other infectious risk factors were not 
subjected to a thorough diagnosis and analysis. 
   Chronic inflammation associated with rheumatoid 
arthritis, Sjögren’s syndrome, celiac disease, or thyroiditis 
is also considered an important risk factor in the develop-
ment of proliferative diseases of the lymphatic system [13, 
22]. Similar observations were made in the case of NHL 
within the parotid glands [19]. The patients treated in our 
institution, in spite of the existing co-morbidities (such as 
coronary heart disease, hypertension), did not report the 
above-mentioned risk factors.
The direct causes of the increased incidence of malig-
nant lymphomas are not fully understood , but it is prob-
ably related to the increase in exposure to the risk factors 
described above [21].
In conclusions, the test histopathological material was 
dominated by NHL, preceded only by diffuse large B-cell 
lymphoma. Regression and correlation analysis in differ-
ent years showed a statistically significant increase in the 
incidence of NHL (p = 0.0169).
Swollen glands in the neck were the most common first 
clinical symptom of a proliferative process of the lymphat-
ic system.
The frequent presence of NHL within the palatine tonsil 
(40.9% of extranodal location and 54.5% of the extran-
odal location within the whole Waldeyer ring) suggests 
that it should be remembered that there is a possibility 
of lymphoma in the area where squamous cell carcinoma 
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Table 2. The incidence of Hodgkin’s and non-Hodgkin’s lymphomas in the years 2005–2014
Histological type 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total
HL 0 2 1 0 1 0 0 0 0 2 6
NHL 2 5 2 1 8 5 4 5 10 10 52
Total 2 7 3 1 9 5 4 5 10 12 58
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is usually clinically suspected, which is the most common 
malignant tumour of the tonsils.
In the case of head and neck lymphomas, surgery, 
followed by haematology treatment, radiotherapy, and 
dietary and psychological actions, plays an increasingly 
important role in the successful treatment of the patient.
The authors declare no conflict of interest.
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